Literature DB >> 34263376

Correction to: Impact of the Interval Between Neoadjuvant Chemotherapy and Gastrectomy on Short- and Long-Term Outcomes for Patients with Advanced Gastric Cancer.

Augustinas Bausys1,2, Toomas Ümarik3, Martynas Luksta4, Arvo Reinsoo3, Rokas Rackauskas4, Giedre Anglickiene5, Marius Kryzauskas4, Kristina Tõnismäe6, Veslava Senina7, Dmitrij Seinin7, Rimantas Bausys4,8, Kestutis Strupas4.   

Abstract

Entities:  

Year:  2021        PMID： 34263376     DOI： 10.1245/s10434-021-10462-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  1 in total

1.  Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.

Authors:  Masaaki Iwatsuki; Hiroyuki Orita; Kazuma Kobayashi; Shigekazu Hidaka; Takaaki Arigami; Tetsuya Kusumoto; Hironaga Satake; Eiji Oki; Satoshi Tsutsumi; Kazutoshi Tobimatsu; Mototsugu Shimokawa; Hiroshi Saeki; Akitaka Makiyama; Hideo Baba; Masaki Mori
Journal:  Gastric Cancer       Date:  2021-08-11       Impact factor: 7.370
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.